You can buy or sell BMY and other stocks, options, ETFs, and crypto commission-free!
Bristol-Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. The firm offers chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. Read More The company was founded in August 1933 and is headquartered in New York, NY.
New York, New York
52 Week High
52 Week Low
BRIEF-Bristol Myers Squibb Announces Acceptance Of U.S., EU Regulatory Filings For Opdivo Plus Yervoy Combined With Limited Chemotherapy In First-Line Lung Cancer
April 8 (Reuters) - Bristol-Myers Squibb Co: * BRISTOL MYERS SQUIBB ANNOUNCES ACCEPTANCE OF U.S. AND EU REGULATORY FILINGS FOR OPDIVO (NIVOLUMAB) PLUS YERVOY (
BRIEF-Bristol Myers Squibb Expands Patient Support Programs To Help Newly Uninsured Patients In The U.S.
April 7 (Reuters) - Bristol-Myers Squibb Co: * BRISTOL MYERS SQUIBB EXPANDS PATIENT SUPPORT PROGRAMS TO HELP NEWLY UNINSURED PATIENTS IN THE U.S. * BRISTOL-MY
— per share
Available May 7, Pre-Market